skip to main content
US FlagAn official website of the United States government
dot gov icon
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
https lock icon
Secure .gov websites use HTTPS
A lock ( lock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Attention:

The NSF Public Access Repository (PAR) system and access will be unavailable from 10:00 PM ET on Thursday, February 12 until 1:00 AM ET on Friday, February 13 due to maintenance. We apologize for the inconvenience.


Title: How do stretch rate, temperature, and solvent exchange affect elastic network rupture?
In this study, we investigate three different polymeric networks in terms of their tensile strength as a function of stretching rate, or temperature, or medium viscosity.  more » « less
Award ID(s):
2204079
PAR ID:
10545955
Author(s) / Creator(s):
; ; ; ; ; ; ; ; ;
Publisher / Repository:
Royal Society of Chemistry
Date Published:
Journal Name:
Soft Matter
ISSN:
1744-683X
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. Warren Piers (Ed.)
    Although cobalt( i ) bis-phosphine complexes have been implicated in many selective C–C bond-forming reactions, until recently relatively few of these compounds have been fully characterized or have been shown to be intermediates in catalytic reactions. In this paper we present a new practical method for the synthesis and isolation of several cobalt( i )-bis-phosphine complexes and their use in Co( i )-catalyzed reactions. We find that easily prepared ( in situ generated or isolated) bis-phosphine and (2,6- N -aryliminoethyl)pyridine (PDI) cobalt( ii ) halide complexes are readily reduced by 1,4-bis-trimethylsilyl-1,4-dihydropyrazine or commercially available lithium nitride (Li 3 N), leaving behind only innocuous volatile byproducts. Depending on the structures of the bis-phosphines, the cobalt( i ) complex crystallizes as a phosphine-bridged species [(P∼P)(X)Co I [μ-(P∼P)]Co I (X)(P∼P)] or a halide-bridged species [(P∼P)Co I [μ-(X)] 2 Co I (P∼P)]. Because the side-products are innocuous, these methods can be used for the in situ generation of catalytically competent Co( i ) complexes for a variety of low-valent cobalt-catalyzed reactions of even sensitive substrates. These complexes are also useful for the synthesis of rare cationic [(P∼P)Co I -η 4 -diene] + X − or [(P∼P)Co I -η 6 -arene] + X − complexes, which are shown to be excellent single-component catalysts for the following regioselective reactions of dienes: heterodimerizations with ethylene or methyl acrylate, hydroacylation and hydroboration. The reactivity of the single-component catalysts with the in situ generated species are also documented. 
    more » « less
  2. Abstract BackgroundWe hypothesized that alemtuzumab use is safe in pediatric kidney transplant recipients (KTRs) with equivalent long‐term outcomes compared to other induction agents. MethodsUsing pediatric kidney transplant recipient data in the UNOS database between January 1, 2000, and June 30, 2022, multivariate logistic regression, multivariable Cox regression, and survival analyses were utilized to estimate the likelihoods of 1st‐year and all‐time hospitalizations, acute rejection, CMV infection, delayed graft function (DGF), graft loss, and patient mortality among recipients of three common induction regimens (ATG, alemtuzumab, and basiliximab). ResultsThere were no differences in acute rejection or graft failure among induction or maintenance regimens. Basiliximab was associated with lower odds of DGF in deceased donor recipients (OR 0.77 [0.60–0.99],p = .04). Mortality was increased in patients treated with steroid‐containing maintenance (HR 1.3 [1.005–1.7]p = .045). Alemtuzumab induction correlated with less risk of CMV infection than ATG (OR 0.76 [0.59–0.99],p = .039). Steroid‐containing maintenance conferred lower rate of PTLD compared to steroid‐free maintenance (HR 0.59 [0.4–0.8]p = .001). Alemtuzumab was associated with less risk of hospitalization within 1 year (OR 0.79 [0.67–0.95]p = .012) and 5 years (HR 0.54 [0.46–0.65]p < .001) of transplantation. Steroid maintenance also decreased 5 years hospitalization risk (HR 0.78 [0.69–0.89]p < .001). ConclusionsPediatric KTRs may be safely treated with alemtuzumab induction without increased risk of acute rejection, DGF, graft loss, or patient mortality. The decreased risk of CMV infections and lower hospitalization rates compared to other agents make alemtuzumab an attractive choice for induction in pediatric KTRs, especially in those who cannot tolerate ATG. 
    more » « less
  3. Since the first phylogenetic study of the order Batrachospermales, Batrachospermum was shown to be paraphyletic. Subsequently, sections of the genus have been methodically investigated using DNA sequences and morphology in order to propose new genera and delineate species. Batrachospermum section Turfosa is the last section with multiple species yet to be examined. New sequence data of specimens from Europe and the United States were combined with the sparse sequence data already available. Phylogenetic analyses using rbcL and COI- 5P sequences showed this section to be a wellsupported clade, distinct from Batrachospermum section Batrachospermum and its segregate genera. Section Turfosa is raised to the generic rank as Paludicola gen. nov. Substantial genetic variation within the genus was discovered and 12 species are recognized based on DNA sequence data as well as morphological characters and geographic distribution. The following morphological characters were applied to distinguish species: branching pattern (pseudodichotomous or irregular), whorl size (reduced or well developed), primary fascicles (curved or straight), spermatangia origin (primary or secondary fascicles), and carposporophyte arrangement (loose or dense). Previously published species were transferred to the new genus: P. turfosa, P. keratophyta, P. orthosticha, P. phangiae, and P. periploca. Seven new species are proposed as follows: P. groenbladii from Europe; P. communis, P. johnhallii, and P. leafensis from North America; and P. aquanigra, P. diamantinensis, and P. turfosiformis from Brazil. In addition, three unsequenced species in the section, P. bakarensis, P. gombakensis, and P. tapirensis, were transferred to the new genus. 
    more » « less
  4. <p>The data was downloaded and captured through MBSE online learning modules. Deidentified learners&#39; activities within the modules, such as clickstreams and assignments, were captured in the data/</p> <p>&bull; All files here are student submissions to one or more of the modules in the MBSE program.</p> <p>&bull; All user data has either been removed or redacted from the submission.</p> <p>&bull; &ldquo;Andrew Hurt&rdquo; is not a student and none of these files came from him. He is the person who did the redaction.</p> <p>&bull; The naming structure of the files is as follows: [Module number]-[Module Offering Date]-[Submission Number]-[Part Number of Submission]. Example: M5-040422-S1-Part3. This file is from Module 5, which was offered on April 4, 2022, it is submission 1, and part 3 of submission 1.</p> <p>&bull; Note that submissions within or between modules are not necessarily connected to specific students. So &ldquo;Submission 1&rdquo; from module 5 is not the same user as &ldquo;Submission 1&rdquo; from module 6.</p> <p>&bull; Not all submissions have multiple parts.</p> <p>&bull; No .mdzip files (proprietary MagicDraw software files) have been included in this list.</p> <p>&bull; If a module or folder in the module is missing content from a particular offering, it is because either no one submitted anything or because the file was a .mdzip file and was not downloaded.</p> <p>&nbsp;</p> 
    more » « less
  5. OBJECTIVE:To determine biomarkers other than CA 125 that could be used in identifying early-stage ovarian cancer. DATA SOURCES:Ovid MEDLINE ALL, EMBASE, Web of Science Core Collection, ScienceDirect, Clinicaltrials.gov, and CAB Direct were searched for English-language studies between January 2008 and April 2023 for the concepts of high-grade serous ovarian cancer, testing, and prevention or early diagnosis. METHODS OF STUDY SELECTION:The 5,523 related articles were uploaded to Covidence. Screening by two independent reviewers of the article abstracts led to the identification of 245 peer-reviewed primary research articles for full-text review. Full-text review by those reviewers led to the identification of 131 peer-reviewed primary research articles used for this review. TABULATION, INTEGRATION, AND RESULTSOf 131 studies, only 55 reported sensitivity, specificity, or area under the curve (AUC), with 36 of the studies reporting at least one biomarker with a specificity of 80% or greater specificity or 0.9 or greater AUC. CONCLUSION:These findings suggest that although many types of biomarkers are being tested in ovarian cancer, most have similar or worse detection rates compared with CA 125 and have the same limitations of poor detection rates in early-stage disease. However, 27.5% of articles (36/131) reported biomarkers with better sensitivity and an AUC greater than 0.9 compared with CA 125 alone and deserve further exploration. 
    more » « less